Skip to main content

Table 2 Clinicopathological features of GATA3 negative breast cancers

From: Cytokeratin 7-negative and GATA binding protein 3-negative breast cancers: Clinicopathological features and prognostic significance

Nottingham gradeLow-grade (Grade 1 and Grade 2)High-grade (Grade 3)
Gata-3 expressionNegativePositiveP-valueNegativePositiveP-value
Agea (N)69 ± 6.7 (7)64 ± 1.1 (152)0.355057 ± 1.8 (54)62 ± 1.4 (142)0.0732
Nottingham Grade     <0.0001
 11 (2%)47 (98%)    
 26 (5%)105 (95%)    
 3   54 (28%)142 (72%) 
pT stage  0.4673  0.2223
 14 (3%)112 (97%) 31 (32%)67 (69%) 
 23 (9%)31 (91%) 15 (21%)58 (79%) 
 305 (100%) 6 (40%)9 (60%) 
 404 (100%) 1 (14%)6 (86%) 
pN stage  0.4247  0.2580
 03 (3%)93 (97%) 32 (32%)66 (67%) 
 11 (3%)33 (97%) 10 (20%)40 (80%) 
 21 (17%)5 (83%) 2 (17%)10 (83%) 
 305 (100%) 05 (100%) 
 X2 (11%)16 (89%) 9 (33%)18 (67%) 
pM stage  0.6172  0.9294
 05 (5%)106 (95%) 36 (28%)91 (72%) 
 100 1 (33%)2 (67%) 
 x2 (8%)24 (92%) 12 (31%)51 (69%) 
Chemo/radiation Therapy  0.2952  0.2785
 Yes4 (4%)103 (96%) 39 (29%)94 (71%) 
 No3 (8%)33 (91%) 10 (21%)37 (79%) 
  1. aAge: mean ± SEM (standard error of mean)